DRD1 and breast carcinoma: In the study constructed to investigate the impact of substrate stiffness on breast cancer cell volume homeostasis, the treatment of the MCF-7 cell line with D1R inhibitor (SCH23390) caused a decrease in cell volume, abolishing to some extent the increase in cell volume triggered by growing substrate stiffness [87].